Bower, Jacquelyn J.
Vance, Leah D.
Psioda, Matthew
Smith-Roe, Stephanie L.
Simpson, Dennis A.
Ibrahim, Joseph G.
Hoadley, Katherine A.
Perou, Charles M.
Kaufmann, William K.
Article History
Received: 15 August 2016
Accepted: 7 February 2017
First Online: 31 March 2017
Competing interests
: C.M.P. is an equity stock holder and member of the Board of Directors of BioClassifier LLC and GeneCentric Diagnostics. C.M.P. is also listed as an inventor on a patent application on the PAM50 molecular assay. The remaining authors declare that they have no competing interests.